Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
Moderna (Nasdaq: MRNA) will present at the 44th annual J.P.
Rhea-AI Summary
Moderna (Nasdaq: MRNA) will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12 at 7:30 p.m. ET / 4:30 p.m. PT. A live webcast will be available under "Events and Presentations" in the Investors section at investors.modernatx.com. A replay will be archived on Moderna's website for at least 30 days following the presentation.
Details
News Market Reaction – MRNA
On Dec 17, the day this news came out, MRNA closed 2.07% above the previous close.
Data tracked by StockTitan Argus for the Dec 17 session.
Key Figures
- Conference edition
- 44th annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 12
- Conference presentation date
- Presentation time ET
- 7:30 p.m. ET
- Scheduled presentation time
- Presentation time PT
- 4:30 p.m. PT
- Scheduled presentation time
- Webcast replay duration
- 30 days
- Replay archived on company website
Historical Context
-
EMA committee issued positive opinion for mNEXSPIKE COVID-19 vaccine.
-
Analyst Day outlined growth strategy, cost reductions, and pipeline plans.
-
Announced up to $1.5B non-dilutive term loan facility with Ares.
-
Onshoring U.S. Drug Product manufacturing with >$140M investment.
-
Announced presentation at Piper Sandler healthcare conference with webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p.m. ET / 4:30 p.m. PT.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.